Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

por Zhao, Ming, DiPeri, Timothy P., Raso, Maria Gabriela, Zheng, Xiaofeng, Rizvi, Yasmeen Qamar, Evans, Kurt W., Yang, Fei, Akcakanat, Argun, Roberto Estecio, Marco, Tripathy, Debu, Dumbrava, Ecaterina E., Damodaran, Senthil, Meric-Bernstam, Funda
Publicado 2023

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

por Ueno, Naoto T., Tahara, Rie K., Fujii, Takeo, Reuben, James M., Gao, Hui, Saigal, Babita, Lucci, Anthony, Iwase, Toshiaki, Ibrahim, Nuhad K., Damodaran, Senthil, Shen, Yu, Liu, Diane D., Hortobagyi, Gabriel N., Tripathy, Debu, Lim, Bora, Chasen, Beth A.
Publicado 2019

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

por Saridogan, Turcin, Akcakanat, Argun, Zhao, Ming, Evans, Kurt W., Yuca, Erkan, Scott, Stephen, Kirby, Bryce P., Zheng, Xiaofeng, Ha, Min Jin, Chen, Huiqin, Ng, Patrick K. S., DiPeri, Timothy P., Mills, Gordon B., Rodon Ahnert, Jordi, Damodaran, Senthil, Meric-Bernstam, Funda
Publicado 2023

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

por Irajizad, Ehsan, Wu, Ranran, Vykoukal, Jody, Murage, Eunice, Spencer, Rachelle, Dennison, Jennifer B., Moulder, Stacy, Ravenberg, Elizabeth, Lim, Bora, Litton, Jennifer, Tripathym, Debu, Valero, Vicente, Damodaran, Senthil, Rauch, Gaiane M., Adrada, Beatriz, Candelaria, Rosalind, White, Jason B., Brewster, Abenaa, Arun, Banu, Long, James P., Do, Kim Anh, Hanash, Sam, Fahrmann, Johannes F.
Publicado 2022

Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial

por Abuhadra, Nour, Sun, Ryan, Yam, Clinton, Rauch, Gaiane M., Ding, Qingqing, Lim, Bora, Thompson, Alastair M., Mittendorf, Elizabeth A., Adrada, Beatriz E., Damodaran, Senthil, Virani, Kiran, White, Jason, Ravenberg, Elizabeth, Sun, Jia, Choi, Jaihee, Candelaria, Rosalind, Arun, Banu, Ueno, Naoto T., Santiago, Lumarie, Saleem, Sadia, Abouharb, Sausan, Murthy, Rashmi K., Ibrahim, Nuhad, Sahin, Aysegul, Valero, Vicente, Symmans, William Fraser, Litton, Jennifer K., Tripathy, Debu, Moulder, Stacy, Huo, Lei
Publicado 2023

Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer

por Abuhadra, Nour, Sun, Ryan, Litton, Jennifer K., Rauch, Gaiane M., Yam, Clinton, Chang, Jeffrey T., Seth, Sahil, Bassett, Roland, Lim, Bora, Thompson, Alastair M., Mittendorf, Elizabeth, Adrada, Beatriz E., Damodaran, Senthil, White, Jason, Ravenberg, Elizabeth, Candelaria, Rosalind, Arun, Banu, Ueno, Naoto T., Santiago, Lumarie, Saleem, Sadia, Abouharb, Sausan, Murthy, Rashmi K., Ibrahim, Nuhad, Sahin, Aysegul A., Valero, Vicente, Symmans, William Fraser, Tripathy, Debu, Moulder, Stacy, Huo, Lei
Publicado 2022

PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens

por Chen, Hui, Ding, Qingqing, Khazai, Laila, Zhao, Li, Damodaran, Senthil, Litton, Jennifer K., Rauch, Gaiane M., Yam, Clinton, Chang, Jeffrey T., Seth, Sahil, Lim, Bora, Thompson, Alastair M., Mittendorf, Elizabeth A., Adrada, Beatriz, Virani, Kiran, White, Jason B., Ravenberg, Elizabeth, Song, Xingzhi, Candelaria, Rosalind, Arun, Banu, Ueno, Naoto T., Santiago, Lumarie, Saleem, Sadia, Abouharb, Sausan, Murthy, Rashmi K., Ibrahim, Nuhad, Routbort, Mark J., Sahin, Aysegul, Valero, Vicente, Symmans, William Fraser, Tripathy, Debu, Wang, Wei-Lien, Moulder, Stacy, Huo, Lei
Publicado 2023